These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 16641611

  • 1. Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation.
    Sengul S, Keven K, Gormez U, Kutlay S, Erturk S, Erbay B.
    Transplantation; 2006 Apr 27; 81(8):1216-9. PubMed ID: 16641611
    [Abstract] [Full Text] [Related]

  • 2. Serial soluble CD30 measurements as a predictor of kidney graft outcome.
    Halim MA, Al-Otaibi T, Al-Muzairai I, Mansour M, Tawab KA, Awadain WH, Balaha MA, Said T, Nair P, Nampoory MR.
    Transplant Proc; 2010 Apr 27; 42(3):801-3. PubMed ID: 20430176
    [Abstract] [Full Text] [Related]

  • 3. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection.
    Wang D, Wu GJ, Wu WZ, Yang SL, Chen JH, Wang H, Lin WH, Wang QH, Zeng ZX, Tan JM.
    Transpl Immunol; 2007 Jun 27; 17(4):278-82. PubMed ID: 17493531
    [Abstract] [Full Text] [Related]

  • 4. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ, Darwish AA, Gras J, Wieërs G, Cornet A, Robert A, Mourad M, Malaise J, de Ville de Goyet J, Reding R, Latinne D.
    Transpl Immunol; 2007 Jun 27; 17(4):283-7. PubMed ID: 17493532
    [Abstract] [Full Text] [Related]

  • 5. High pretransplantation soluble CD30 levels: impact in renal transplantation.
    Giannoli C, Bonnet MC, Perrat G, Houillon A, Reydet S, Pouteil-Noble C, Villar E, Lefrançois N, Morelon E, Dubois V.
    Transplant Proc; 2007 Oct 27; 39(8):2574-5. PubMed ID: 17954178
    [Abstract] [Full Text] [Related]

  • 6. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
    Matinlauri I, Höckerstedt K, Isoniemi H.
    Transplant Proc; 2006 Dec 27; 38(10):3601-4. PubMed ID: 17175343
    [Abstract] [Full Text] [Related]

  • 7. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
    Solgi G, Amirzagar AA, Pourmand G, Mehrsai AR, Taherimahmoudi M, Baradaran N, Nicknam MH, Ebrahimi Rad MR, Saraji A, Asadpoor AA, Moheiydin M, Nikbin B.
    Transplant Proc; 2009 Sep 27; 41(7):2800-4. PubMed ID: 19765439
    [Abstract] [Full Text] [Related]

  • 8. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
    Ayed K, Abdallah TB, Bardi R, Abderrahim E, Kheder A.
    Transplant Proc; 2006 Sep 27; 38(7):2300-2. PubMed ID: 16980071
    [Abstract] [Full Text] [Related]

  • 9. Prediction of acute renal allograft rejection in early post-transplantation period by soluble CD30.
    Dong W, Shunliang Y, Weizhen W, Qinghua W, Zhangxin Z, Jianming T, He W.
    Transpl Immunol; 2006 Jun 27; 16(1):41-5. PubMed ID: 16701175
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection.
    Pelzl S, Opelz G, Daniel V, Wiesel M, Süsal C.
    Transplantation; 2003 Feb 15; 75(3):421-3. PubMed ID: 12589170
    [Abstract] [Full Text] [Related]

  • 11. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
    Kim MS, Kim HJ, Kim SI, Ahn HJ, Ju MK, Kim HJ, Jeon KO, Kim YS.
    Transplantation; 2006 Dec 27; 82(12):1602-5. PubMed ID: 17198243
    [Abstract] [Full Text] [Related]

  • 12. High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feasible marker for prediction of kidney allograft rejection?
    Altermann W, Schlaf G, Rothhoff A, Seliger B.
    Nephrol Dial Transplant; 2007 Oct 27; 22(10):2795-9. PubMed ID: 17616534
    [Abstract] [Full Text] [Related]

  • 13. Association of elevated pretransplant sCD30 levels with graft loss in 206 patients treated with modern immunosuppressive therapies after renal transplantation.
    Heinemann FM, Rebmann V, Witzke O, Philipp T, Broelsch CE, Grosse-Wilde H.
    Transplantation; 2007 Mar 27; 83(6):706-11. PubMed ID: 17414702
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K, Abbasi MA, Farokhi B, Abbasi A, Fallah P, Seifee MH, Ghadimi N, Rezaie AR.
    Exp Clin Transplant; 2009 Dec 27; 7(4):237-40. PubMed ID: 20353374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.